(Total Views: 359)
Posted On: 03/20/2020 10:39:43 AM
Post# of 149059
Agree on your call for much better PR - founder of ridgeback therapeutics is currently on CNBC
they have 30k doses on hand
They said they want to file an IND next week
They have safety in monkeys - not humans yet. They did test in animals.
The advantage is they have a drug on market for Ebola.
His deliver is excellent and succinct
How to they get on CNBC at 10:30?
they have 30k doses on hand
They said they want to file an IND next week
They have safety in monkeys - not humans yet. They did test in animals.
The advantage is they have a drug on market for Ebola.
His deliver is excellent and succinct
How to they get on CNBC at 10:30?
(0)
(0)Scroll down for more posts ▼
